We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sponsors who do not comply with the clinical trial registration requirements in the FDA Amendments Act of 2007 (FDAAA) are potentially liable to significant civil monetary penalties (CMPs) even though the FDA is probably not actively looking to penalize the unintentionally noncompliant, experts say.